Literature DB >> 17671086

Quality control of eukaryotic mRNA: safeguarding cells from abnormal mRNA function.

Olaf Isken1, Lynne E Maquat.   

Abstract

Cells routinely make mistakes. Some mistakes are encoded by the genome and may manifest as inherited or acquired diseases. Other mistakes occur because metabolic processes can be intrinsically inefficient or inaccurate. Consequently, cells have developed mechanisms to minimize the damage that would result if mistakes went unchecked. Here, we provide an overview of three quality control mechanisms--nonsense-mediated mRNA decay, nonstop mRNA decay, and no-go mRNA decay. Each surveys mRNAs during translation and degrades those mRNAs that direct aberrant protein synthesis. Along with other types of quality control that occur during the complex processes of mRNA biogenesis, these mRNA surveillance mechanisms help to ensure the integrity of protein-encoding gene expression.

Mesh:

Substances:

Year:  2007        PMID: 17671086     DOI: 10.1101/gad.1566807

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  272 in total

1.  Translation drives mRNA quality control.

Authors:  Christopher J Shoemaker; Rachel Green
Journal:  Nat Struct Mol Biol       Date:  2012-06-05       Impact factor: 15.369

2.  Differential RNA expression of KIR alleles.

Authors:  Colum McErlean; Asensio A Gonzalez; Rodat Cunningham; Ashley Meenagh; Tanya Shovlin; Derek Middleton
Journal:  Immunogenetics       Date:  2010-05-08       Impact factor: 2.846

3.  The human core exosome interacts with differentially localized processive RNases: hDIS3 and hDIS3L.

Authors:  Rafal Tomecki; Maiken S Kristiansen; Søren Lykke-Andersen; Aleksander Chlebowski; Katja M Larsen; Roman J Szczesny; Karolina Drazkowska; Agnieszka Pastula; Jens S Andersen; Piotr P Stepien; Andrzej Dziembowski; Torben Heick Jensen
Journal:  EMBO J       Date:  2010-06-08       Impact factor: 11.598

4.  Underexpression and abnormal localization of ATM products in ataxia telangiectasia patients bearing ATM missense mutations.

Authors:  Virginie Jacquemin; Guillaume Rieunier; Sandrine Jacob; Dorine Bellanger; Catherine Dubois d'Enghien; Anthony Laugé; Dominique Stoppa-Lyonnet; Marc-Henri Stern
Journal:  Eur J Hum Genet       Date:  2011-11-09       Impact factor: 4.246

5.  A genome-wide RNAi screen identifies genes regulating the formation of P bodies in C. elegans and their functions in NMD and RNAi.

Authors:  Yinyan Sun; Peiguo Yang; Yuxia Zhang; Xin Bao; Jun Li; Wenru Hou; Xiangyu Yao; Jinghua Han; Hong Zhang
Journal:  Protein Cell       Date:  2011-12-17       Impact factor: 14.870

6.  Characterization of NOL7 gene point mutations, promoter methylation, and protein expression in cervical cancer.

Authors:  Colleen L Doçi; Tanmayi P Mankame; Alexander Langerman; Kelly R Ostler; Rajani Kanteti; Timothy Best; Kenan Onel; Lucy A Godley; Ravi Salgia; Mark W Lingen
Journal:  Int J Gynecol Pathol       Date:  2012-01       Impact factor: 2.762

Review 7.  DRiPs solidify: progress in understanding endogenous MHC class I antigen processing.

Authors:  Jonathan W Yewdell
Journal:  Trends Immunol       Date:  2011-09-29       Impact factor: 16.687

8.  A single-base substitution suppresses flower color mutation caused by a novel miniature inverted-repeat transposable element in gentian.

Authors:  Masahiro Nishihara; Takashi Hikage; Eri Yamada; Takashi Nakatsuka
Journal:  Mol Genet Genomics       Date:  2011-10-15       Impact factor: 3.291

Review 9.  P-bodies and stress granules: possible roles in the control of translation and mRNA degradation.

Authors:  Carolyn J Decker; Roy Parker
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-09-01       Impact factor: 10.005

10.  A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection.

Authors:  Toni I Pollin; Coleen M Damcott; Haiqing Shen; Sandra H Ott; John Shelton; Richard B Horenstein; Wendy Post; John C McLenithan; Lawrence F Bielak; Patricia A Peyser; Braxton D Mitchell; Michael Miller; Jeffrey R O'Connell; Alan R Shuldiner
Journal:  Science       Date:  2008-12-12       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.